For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of more than 20 marketed vaccines is the broadest in the industry, helping to protect people throughout their lives. We believe prevention, at scale and for impact, is the best health investment for society, patients, and the economy. Vaccine preventable diseases are a significant burden on society and healthcare systems; approximately $1 trillion in productivity is lost each year due to preventable conditions. This includes the impact from the 330,000 older adults hospitalized globally each year with RSV, the approximately 1 in 3 people who will develop shingles in their lifetime and the 3-11% of people infected with seasonal influenza each year. Our Vaccines portfolio will reach over 1 billion people globally this decade. Each year, around 40% of children globally receive a GSK vaccine and GSK is well-placed to lead in the growing adult immunization market. GSK's US vaccines business is organized into local ecosystem teams, designed to support the unique needs of the customer base in the given geography. In a local ecosystem commercial model, there are multiple customer-facing roles, each with unique customers/call points, but all dependent upon a high degree of collaboration. The ecosystem's Key Account Lead, or VKAL, is pivotal in most ecosystems, owning the B2B customer relationship in the largest and most complex healthcare delivery networks (IDN's, State CDC Awardees and similarly structured systems). The role of the VKAL is to engage C/D level clinical & non-clinical stakeholders within large health systems to understand unique customer needs/priorities and to deliver a customized value proposition. The VKAL must possess strong customer engagement skills, knowledge of healthcare contracting, knowledge of IDN decision making and the ability to work across a complex group of internal and external stakeholders.